cd38 inhibitor synergy with nnmt inhibitor 5-amino-1mq nad+ inhibition counteracts tubular senescence and fibrosis in early stages of chronic kidney disease: Cell Reports US20200102274A1 - Quinoline derived small
US20200102274A1 Quinoline derived small molecule inhibitors of nicotinamide n methyltransferase (nnmt) and uses thereof Google Patents Targeting CD38 dependent NAD+ metabolism to mitigate multiple organ fibrosis ScienceDirect Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers Emerging chemical strategies for CD38 inhibition: restoring NAD+ metabolism and disease control ScienceDirect
Pay in 4 interest-free payments of $7.17 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



